{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:57:38Z","timestamp":1760385458559},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.psychres.2015.12.030","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T12:15:39Z","timestamp":1450872939000},"page":"71-74","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Factors associated with discontinuation of aripiprazole treatment after switching from other antipsychotics in patients with chronic schizophrenia: A prospective observational study"],"prefix":"10.1016","volume":"236","author":[{"given":"Yoshikazu","family":"Takaesu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishiro","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Murakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutada","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2015.12.030_bib1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1017\/S1461145710000490","article-title":"Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial","volume":"13","author":"Fleischhacker","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2015.12.030_bib2","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1517\/14656566.3.12.1773","article-title":"Aripiprazole: profile on efficacy and safety","volume":"3","author":"Goodnick","year":"2002","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.psychres.2015.12.030_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1744-859X-9-35","article-title":"A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting","volume":"9","author":"Hsieh","year":"2010","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2015.12.030_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2302\/kjm.45.95","article-title":"Current topics in neuroleptic-induced extrapyramidal symptoms in Japan","volume":"45","author":"Inada","year":"1996","journal-title":"Keio J. Med."},{"key":"10.1016\/j.psychres.2015.12.030_bib5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00213-006-0428-x","article-title":"The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine","volume":"187","author":"Kern","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2015.12.030_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/WNF.0b013e31819a68b5","article-title":"Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia","volume":"32","author":"Kim","year":"2009","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.psychres.2015.12.030_bib7","first-page":"409","article-title":"Switching of antipsychotics to aripiprazole in the treatment of schizophrenia","volume":"32","author":"Lin","year":"2009","journal-title":"Chang Gung Med. J."},{"key":"10.1016\/j.psychres.2015.12.030_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0920-9964(03)00050-1","article-title":"Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials","volume":"61","author":"Marder","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2015.12.030_bib9","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.4088\/JCP.v69n0702","article-title":"A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine","volume":"69","author":"Newcomer","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2015.12.030_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/096228029900800203","article-title":"The interpretation of diagnostic tests","volume":"8","author":"Shapiro","year":"1999","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.psychres.2015.12.030_bib11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/appi.ajp.2011.10111609","article-title":"A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP)","volume":"168","author":"Stroup","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2015.12.030_bib12","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","article-title":"Measuring the accuracy of diagnostic systems","volume":"240","author":"Swets","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.psychres.2015.12.030_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00213-013-3154-1","article-title":"A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder","volume":"228","author":"Takeuchi","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2015.12.030_bib14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/JCP.0b013e3181accfec","article-title":"Predictors of clinical worsening after a switch to aripiprazole in patients with schizophrenia: a 1-year naturalistic follow-up study","volume":"29","author":"Takeuchi","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2015.12.030_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1440-1819.2009.02036.x","article-title":"Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One-year follow-up study","volume":"64","author":"Takeuchi","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2015.12.030_bib16","first-page":"905","article-title":"Reliability and validity of Subjective Well-being under Neuroleptic drug treatment Short form\u00a0Japanese version (SWNS-J)","volume":"6","author":"Watanabe","year":"2003","journal-title":"Jpn. J. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.psychres.2015.12.030_bib17","first-page":"S1","article-title":"Translating the psychopharmacology of antipsychotics to individualized treatment for severe mental illness: a roadmap","volume":"68","author":"Weiden","year":"2007","journal-title":"J. Clin. Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178115308702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178115308702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T01:48:57Z","timestamp":1572659337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178115308702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":17,"alternative-id":["S0165178115308702"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2015.12.030","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with discontinuation of aripiprazole treatment after switching from other antipsychotics in patients with chronic schizophrenia: A prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2015.12.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}